Comparison of three frailty models and a sarcopenia model in elderly patients with chronic obstructive pulmonary disease.
Aged
Checklist
/ methods
Cross-Sectional Studies
Female
Frail Elderly
/ statistics & numerical data
Frailty
/ diagnosis
Geriatric Assessment
/ methods
Humans
Japan
Male
Outpatients
/ statistics & numerical data
Prevalence
Prognosis
Pulmonary Disease, Chronic Obstructive
/ diagnosis
Quality of Life
Risk Assessment
/ methods
Risk Factors
Sarcopenia
/ diagnosis
Kihon Checklist
chronic obstructive pulmonary disease
elderly
frailty
sarcopenia
Journal
Geriatrics & gerontology international
ISSN: 1447-0594
Titre abrégé: Geriatr Gerontol Int
Pays: Japan
ID NLM: 101135738
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
revised:
19
06
2019
received:
28
03
2019
accepted:
21
06
2019
pubmed:
17
7
2019
medline:
15
2
2020
entrez:
17
7
2019
Statut:
ppublish
Résumé
Frailty and sarcopenia affect the prognosis and quality of life of patients with chronic obstructive pulmonary disease (COPD). However, it remains uncertain which model is the most suitable for evaluating vulnerability in patients with COPD. We evaluated the validity of three frailty models - the Kihon Checklist (KCL), the Japanese version of the Cardiovascular Health Study and the Study of Osteoporotic Fractures - and one sarcopenia model for older patients with COPD. This cross-sectional study included 201 older (aged ≥65 years) outpatients with COPD. We used three frailty models and one sarcopenia model to identify their correlation with various indices that can evaluate the status of COPD and determine the most ideal model for evaluating vulnerability in patients with COPD. The highest prevalence of frailty (38%) and lowest prevalence of robustness (26%) were observed using the KCL. Although all models reflected the characteristics of COPD, the KCL yielded the strongest correlations with clinically important physical, psychological and prognostic indices. The KCL yielded statistically significant differences in almost all indices among the three intergroup comparisons (robust, pre-frailty and frailty). The KCL was superior in extracting mood disorders to the other models. Although all investigated models were useful, the KCL was the most suitable for evaluating the frailty status and might enable interventions in patients with COPD. Geriatr Gerontol Int 2019; 19: 896-901.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
896-901Informations de copyright
© 2019 Japan Geriatrics Society.
Références
Morley JE, Vellas B, van Kan GA et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013; 14: 392-397.
Galizia G, Cacciatore F, Testa G et al. Role of clinical frailty on long-term mortality of elderly subjects with and without chronic obstructive pulmonary disease. Aging Clin Exp Res 2011; 23: 118-125.
Lahousse L, Ziere G, Verlinden VJ et al. Risk of frailty in elderly with COPD: a population-based study. J Gerontol A Biol Sci Med Sci 2016; 71: 689-695.
Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review. Eur J Intern Med 2016; 31: 3-10.
Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 2010; 13: 1-7.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet 2013; 381: 752-762.
Malmstrom TK, Miller DK, Morley JE. A comparison of four frailty models. J Am Geriatr Soc 2014; 62: 721-726.
Lin SM, Aliberti MJR, Fortes-Filho SQ et al. Comparison of 3 frailty instruments in a geriatric acute care setting in a low-middle income country. J Am Med Dir Assoc 2018; 19: 310-314.
GOLD. Global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD) 2019. [Cited July 6 2019] Available from URL: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf
Fukutomi E, Okumiya K, Wada T et al. Relationships between each category of 25-item frailty risk assessment (Kihon Checklist) and newly certified older adults under long-term care insurance: a 24-month follow-up study in a rural community in Japan. Geriatr Gerontol Int 2015; 15: 864-871.
Satake S, Senda K, Hong YJ et al. Validity of the Kihon Checklist for assessing frailty status. Geriatr Gerontol Int 2016; 16: 709-715.
Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-M156.
Theou O, Cann L, Blodgett J, Wallace LM, Brothers TD, Rockwood K. Modifications to the frailty phenotype criteria: systematic review of the current literature and investigation of 262 frailty phenotypes in the Survey of Health, Ageing, and Retirement in Europe. Ageing Res Rev 2015; 21: 78-94.
Matsushita E, Okada K, Ito Y et al. Characteristics of physical prefrailty among Japanese healthy older adults. Geriatr Gerontol Int 2017; 17: 1568-1574.
Shariat SF, Roehrborn CG, Lamb DJ, Slawin KM. Notice of duplicate publication: “Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis” (arch intern med. 2008;168[2]:235-236). Arch Intern Med 2008; 168: 2046-2047.
Ensrud KE, Ewing SK, Taylor BC et al. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 2008; 168: 382-389.
Chen LK, Liu LK, Woo J et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014; 15: 95-101.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on sarcopenia in older people. Age Ageing 2010; 39: 412-423.
Lee ES, Park HM. Prevalence of sarcopenia in healthy Korean elderly women. J Bone Metab 2015; 22: 191-195.
Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Leidy NK. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648-654.
Karloh M, Fleig Mayer A, Maurici R, Pizzichini MMM, Jones PW, Pizzichini E. The COPD Assessment test: what do we know so far?: a systematic review and meta-analysis about clinical outcomes prediction and classification of patients into GOLD stages. Chest 2016; 149: 413-425.
Mahler DA, Ward J, Waterman LA, McCusker C, ZuWallack R, Baird JC. Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest 2009; 136: 1473-1479.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
Wilson MM, Thomas DR, Rubenstein LZ et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr 2005; 82: 1074-1081.
Puhan MA, Garcia-Aymerich J, Frey M et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374: 704-711.
Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest 2013; 144: 766-777.
Maddocks M, Kon SS, Canavan JL et al. Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study. Thorax 2016; 71: 988-995.
Bell J. Redefining disease. Clin Med 2010; 10: 584-594.
Nagami S, Oku Y, Yagi N et al. Breathing-swallowing discoordination is associated with frequent exacerbations of COPD. BMJ Open Respir Res 2017; 4: e000202.
Thakur N, Blanc PD, Julian LJ et al. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Int J Chron Obstruct Pulmon Dis 2010; 5: 263-269.